Source: Current Phamaceutical Design. Unidade: FMRP
Subjects: CANNABIS (EFEITOS), FARMACOLOGIA, ANSIEDADE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MARTÍN-SANTOS, R. et al. Acute effects of a single, oral dose of d9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) administration in healthy volunteers. Current Phamaceutical Design, v. 18, n. 32, p. 4966-4979, 2012Tradução . . Disponível em: https://doi.org/10.2174/138161212802884780. Acesso em: 30 maio 2024.APA
Martín-Santos, R., Crippa, J. A. de S., Batalla, A., Bhattacharyya, S., Atakan, Z., Borgwardt, S., et al. (2012). Acute effects of a single, oral dose of d9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) administration in healthy volunteers. Current Phamaceutical Design, 18( 32), 4966-4979. doi:10.2174/138161212802884780NLM
Martín-Santos R, Crippa JA de S, Batalla A, Bhattacharyya S, Atakan Z, Borgwardt S, Allen P, Seal M, Langohr K, Faré M, Zuardi AW, McGuire PK. Acute effects of a single, oral dose of d9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) administration in healthy volunteers [Internet]. Current Phamaceutical Design. 2012 ; 18( 32): 4966-4979.[citado 2024 maio 30 ] Available from: https://doi.org/10.2174/138161212802884780Vancouver
Martín-Santos R, Crippa JA de S, Batalla A, Bhattacharyya S, Atakan Z, Borgwardt S, Allen P, Seal M, Langohr K, Faré M, Zuardi AW, McGuire PK. Acute effects of a single, oral dose of d9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) administration in healthy volunteers [Internet]. Current Phamaceutical Design. 2012 ; 18( 32): 4966-4979.[citado 2024 maio 30 ] Available from: https://doi.org/10.2174/138161212802884780
